Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-14T16:24:23.374Z Has data issue: false hasContentIssue false

Who says what to whom through what channel? Formative communication research on antibiotic resistance messaging for urgent care patients

Published online by Cambridge University Press:  15 October 2024

Rachel B. Wade
Affiliation:
Department of Communication, School of Arts and Sciences, The Ohio State University, Columbus, OH, USA
Monique M. Turner
Affiliation:
Department of Communication, College of Communication Arts and Sciences, Michigan State University, East Lansing, MI, USA
Rana F. Hamdy
Affiliation:
Children’s National Medical Center, Washington, DC, USA
Youjin Jang
Affiliation:
Communicating in Health Impact (CHI) Lab, University of North Carolina, Chapel Hill, NC, USA
Ruth J. Heo
Affiliation:
Department of Communication, College of Communication Arts and Sciences, Michigan State University, East Lansing, MI, USA
Cindy M. Liu*
Affiliation:
Antibiotic Resistance Action Center, Department of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA
*
Corresponding author: Cindy M. Liu; Email: cindyliu@email.gwu.edu

Abstract

Objective:

To explore the source, message, channel, and receiver effects on patient concern for antibiotic resistance, willingness to reduce antibiotic use, and expectations for an antibiotic prescription in a prepandemic sample.

Methods:

We used data reported from a national cross-sectional survey of adults who had visited an urgent care center within the last year. Data were collected from April 4 to April 9, 2017. The survey included an embedded experimental design to test changing effects before versus after message exposure.

Participants:

A national sample of adult participants (n = 610) who had used urgent care at least once in the past year were recruited through GfK’s KnowledgePanelTM. KnowledgePanel survey response rates are typically about 65%. Respondents ranged in age from 18 to 85 and were more likely to be female (377/610; 62%), White (408/610; 67%), and covered by private insurance (414/610; 68%).

Results:

Outcome variables were measured on 4-point scales 1–4 scale, and t-tests were conducted for measures that were collected pre and postmessaging. The majority of participants trusted their doctor and desired them as the source for information regarding antibiotic resistance, followed by field experts (eg, CDC). Direct messaging (eg, email) and targeted advertisements were least preferred.

Conclusions:

This study provides foundational data on patient communication preferences in terms of source, message content, and channel when receiving information on antibiotics and antibiotic resistance, as well as how these factors affect patient concern, willingness, and expectations. Follow-up work is needed to replicate these findings in a postpandemic sample.

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Introduction

Antibiotic resistance is a major global public health crisis. Annually, 2.8 million people in the U.S. are infected with an antibiotic-resistant strain, and approximately 35,000 people die due to resistance. 1 The increase in antibiotic resistance and creation of antibiotic-resistant bacteria result from the overuse of antibiotics, inappropriate prescribing, extensive agricultural use, and a limited number of new antibiotics and alternatives. This leads to antibiotic-resistant bacteria that are resistant to even last-resort antibiotics, resulting in infections that become extremely difficult to treat and run the risk of spreading. Unfortunately, 1 in every 3 antibiotic prescriptions in outpatient settings were inappropriate for the presenting condition. Reference Ventola2

Prior research has attempted to understand the patient’s role in the antibiotic prescribing process both for themselves and their children. Reference Cockburn and Pit3,Reference Mangione-Smith, McGlynn, Elliott, Krogstad and Brook4 Higher antibiotic expectations among patients have been shown to increase the likelihood of an antibiotic prescription. Reference Davey, Pagliari and Hayes5 A patient’s previous experience with antibiotics can also result in self-diagnosis if they present with the same conditions. This results in increased patient expectations which, in turn, leads to patients accessing antibiotics through physician prescriptions, over-the-counter online, other countries, or a previous prescription. This issue is particularly prevalent among urgent care patients, who are much more likely to be inappropriately prescribed antibiotics than patients with similar afflictions seen in retail health clinics. Reference Hyun and Zetts6 Though one strategy is to address physician overprescribing practices, another tactic for understanding and mitigating overuse is patient-focused antibiotic stewardship.

Prior research has found patients are open to receiving targeted communication messages regarding antibiotic resistance. Reference Van Hecke, Butler, Wang and Tonkin-Crine7 Moreover, providing information regarding antibiotic resistance has been shown to effectively mitigate inappropriate use. Reference Thorpe, Sirota, Orbell and Juanchich8 However, much of the work in this space has focused on making message content effective, Reference Roope, Tonkin-Crine and Herd9,Reference Sirota and Juanchich10 with less being known about patients’ preferred methods for receiving these communications. To address this, we take a sender-message-channel-receiver (SMCR) approach. Though simplistic, this model first proffered by D.K. Berlo is foundational in communication studies research today. Reference Roope, Tonkin-Crine and Herd9

Communication scholars and practitioners believe it to be axiomatic that before an effective campaign can be launched, it is critical to understand preferences for who (source) says what (message) through what channel (modality) to whom (target audience) to achieve particular effects. Reference Roope, Tonkin-Crine and Herd9 Preferences for SMCR vary greatly across audiences and contexts; but campaign strategies cannot be developed in full without understanding who the audience trusts, the arguments they will find convincing, and the channels they prefer. Therefore, the variance of SMCR, and subsequent effects, was the focus of this formative research conducted with a national sample of urgent care patients. Urgent care patients were selected given that inappropriate prescription for respiratory conditions is highest in this patient population. Reference Palms, Hicks and Bartoces12 Our objective was to explore each of these components to determine which elements resonate with patients to change their expectations. This study additionally explored the changing levels of antibiotic resistance concern, willingness to reduce use, and expectations for prescription before versus after message exposure.

Methods

Study design

A cross-sectional quantitative survey was conducted using a national sample of participants recruited through GfK’s KnowledgePanelTM, a probability-based online panel of adults that is recruited using address-based sampling. The survey was designed by the authors and Strategies 360, a Washington D.C.-based research firm contracted to implement the study. As part of their demographic profiling, GfK had collected data about urgent care use. This information was used in targeting potential survey participants, as well as in setting demographic quotas. Live telephone surveys were conducted between April 4 and 9, 2017.

The study received ethical approval from the George Washington University Human Subjects Review Board. Post hoc power analysis using G*Power (two-tail; d = .03; ɑ = 0.05; Power =.95) suggests a sample size of 580 to conduct means difference t-tests on independent groups. Considering Strategies 360’s predetermined margin of error for a survey of 610 is ±4.0% at the 95% confidence interval, the study was sufficiently powered. Though an exact response rate was not provided, the typical response rate for KnowledgePanelTM is 65%. Reference Poushter, Gubbala and Lippert13

All participants were asked to confirm they had been an urgent care customer within the last year, and about their health insurance and most frequently visited medical services (Table 1). The survey included one embedded, randomized, experimental component (Figure 1). This design allowed us to make some inferences about the persuasive potential of the messages. Half of the participants (Group A) were asked about their expectations regarding antibiotic prescription before viewing persuasive evidentiary messages. The other half (Group B) received these questions after viewing the messages. Moreover, those in Group A were asked about their willingness to reduce antibiotic use for “bacterial infections” and trust in “your doctor” and Group B participants were asked the same questions but about “viral infections” and “an urgent care doctor,” respectively (Table 2). For all other questions, Groups A and B were treated the same. In addition, all participants responded before and after viewing persuasive messages regarding their concerns and willingness to reduce use.

Table 1. Sample demographics

All n values are out of n = 610.

Figure 1. Flow chart of survey order and experimental design for group A and B.

Table 2. Source trust ratings

a Indicates question that only Group A answered.

b Indicates question that only Group B answered. All other questions were reported by both Group A and B. Likert scaled 1 “very much” to 4 “not at all.”

Measures

The survey included 69 questions, including nine demographic variables, nine questions about urgent care perceptions, two questions capturing health literacy, and 49 questions about antibiotics.

Source

Credibility

Participants indicated how trustworthy they found message sources to be from 1 “very much” to 4 “not at all.” Examples include doctors, the World Health Organization (WHO), and friends/family (Table 2).

Message

Persuasiveness of evidentiary statements

Nine potentially persuasive arguments were presented halfway through the survey. Messages were intended to be diverse and spanned from biological to economic and social reasons. To gauge the persuasiveness of these evidentiary statements, participants were asked to mark how “convincing a reason” each statement was in helping to reduce antibiotic resistance on a scale from 1 “very convincing” to 4 “not convincing at all” (Table 3).

Table 3. Messages: ratings of how convincing each message was and ranking of benefits to help reduce antibiotic resistance

Likert scaled 1 “very convincing” to 4 “not convincing at all.”

Benefits of antibiotic resistance reduction

Participants were asked, “In your own words, what is the most important reason to help reduce antibiotic resistance?” Responses were recorded verbatim and coded to fit nine a priori thematic codes (Table 4).

Table 4. Preferences for channels and benefits of antibiotic resistance reduction

All n values for the preferred methods of communication are out of n = 610. Participants could choose up to 3 channel options. All the n values for the perceived benefits of antibiotic resistance reduction are out of n = 416 due to 194 participants opting not to give an open-ended response. Participant responses were recorded verbatim and coded into one of nine predetermined thematic codes.

Channel

Method of communication

Participants were asked, “Which 3 of the following ways would you most like to get information about antibiotic resistance?” then shown a list of 13 potential communication channels in a randomized order (Table 4).

Antibiotic resistance attitudes and behaviors

Concern

Concern about antibiotic resistance was measured before and after exposure to evidentiary statements from 1 “Very concerned” to 4 “Not concerned at all” but then reverse-coded such that greater values indicated more concern (Table 5).

Table 5. Evidentiary message effects of antibiotic expectation by symptoms, antibiotic resistance concern, and action step willingness

Group A n = 302. Group B n = 308. Expectation for antibiotics by symptom was measured on a 4-point scale and reverse-coded so higher numbers indicate greater expectation. Concern and willingness were also measured on 4-point Likert scales and reverse-coded so higher values indicate greater concern/willingness.

Expectations

Six distinct symptomsFootnote 1 (ie, ear pain, a deep cut/bad scrape, sore throat, fever, cough, stomachache) were presented to participants in random order. Participants were asked how likely they would be to expect antibiotics for each symptom from 1 “definitely expect” to 4 “definitely not expect” (reverse-coded; Table 5). Half of the sample reported expectations before exposure to evidentiary statements (Group A) and the other half reported after exposure (Group B).

Willingness

Willingness to help reduce antibiotic resistance was measured before and after exposure to persuasive messaging from 1 “Very willing” to 4 “Not willing at all” (reverse-coded; Table 5). Participants were asked, “To help reduce antibiotic resistance, how willing would you be to use antibiotics less often for [bacterial/viral] infections?” Half of the sample answered the bacterial question (Group A), the other half (Group B) answered the viral question.

Action steps

Participants indicated how likely they would be to take behavioral steps (eg, asking a provider if there are steps to take to feel better without antibiotics) after exposure to evidentiary statements. Responses ranged from 1 “very likely” to 4 “not likely at all.”

Statistical analysis

All analyses were completed with SPSS 29. For measures that were collected pre- and postmessaging, a paired samples t-test was used to test for changes in response to messages. For measures that were collected across Groups A and B, an independent samples t-test was used to test for changes in response to messages. Our predetermined α level was .05.

Results

Sample results

Adults (n = 610) who had used urgent care at least once in the past year completed this survey (Table 1). Most respondents were 18–44 years old (341/610; 56%), and 53% (322/610) were married. Females comprised 62% (377/610) of the sample, 67% (408/610) were White non-Hispanic, and 26% (158/610) were parents to a 0- to 17-year-old child at the time of the study. Almost all were covered by health insurance (583/610; 95%) with most having private insurance (411/610; 67%).

Survey results

Source

Credibility

Considering the trustworthiness of the message source (Table 2), around 60% (177/299) of the participants placed high trust in their doctor to inform them about the dangers and implications of antibiotic resistance. This was closely followed by 53% strongly trusting both the CDC (317/603) and experts and scientists who study infections (319/603). Only 40% (122/304) “strongly trusted” an urgent care doctor, 38% (230/602) a nurse, 35% (214/604) WHO, and 11% (68/603) their friends and family. Family and friends were shown to have the least amount of trust when concerning information about antibiotic resistance with 50% (300/603) trusting them “a little” or “not at all.”

Messages

Persuasiveness of evidentiary statements

The single most convincing message was “antibiotic-resistant bacteria could turn even a simple cut or scrape into a life-threatening or deadly illness” (260/605; 43%). Moreover, 70% of the respondents found the messages about threats to “common procedures,” (428/607) and antibiotics killing “good bacteria” (421/606) very or somewhat convincing (Table 3). The least convincing messages (ie, a little or not at all convincing) referenced the threat of an “allergic reaction” (240/606; 40%) or “weight gain” (238/607; 39%).

Benefits of antibiotic resistance reduction

One-fourth of the sample (104/416) found “to prevent superbugs” to be one of the most compelling motivators for reducing antibiotic resistance. Similarly, 24% (100/416) reported having antibiotics work when we need them was important, followed by the prevention of routine illnesses from becoming threatening (79/416; 19%). Other motivators were individually selected less than 10% of the time (Table 4).

Channel

Method of communication

Most participants (441/610; 72%) preferred to receive information on antibiotic resistance from their doctor or healthcare professional (Table 4). Other frequently selected channels were healthcare websites (214/610; 35%), professional medical journals (181/610; 30%), and a doctor they know personally but who is not their doctor (173/610; 28%). The least preferred methods were direct communication such as online advertising (10/610 2%), emailing (15/610; 2%), online videos (22/610; 4%), and social media (43/610; 7%). They also infrequently preferred local (66/610; 11%) or national news (95/610; 16%).

Experimental results

Antibiotic resistance attitudes and behaviors

Expectations

Regarding patients’ expectations for receiving antibiotics for certain symptoms, results of an independent samples t-test (ie, differences between Groups A and B; Table 5) found that exposure to evidentiary statements decreased average expectations for cough with a mean difference of -0.38, 95% CI [–0.52, –0.24], t 565.8 = -5.39, P <.001, Cohen’s d = -0.45. Expectations for sore throat also decreased, M DIFF = –0.14, 95% CI [–0.28, –0.01], t 549.4 = -2.02, P < .05, d = -0.17.

Concern

Exposure to evidentiary statements did increase concern about antibiotics. According to a paired samples t-test, this change in mean was significant, M DIFF = 0.32, 95% CI [0.36, 0.25], t 546 = 10.35, P < .001, d = 0.44 (Table 5).

Willingness

We conducted paired samples t-tests to test the change in participants’ willingness to reduce antibiotic use for bacterial and viral infections, detecting a 0.12 (95% CI = 0.19, 0.05; P < .001) and 0.11 (95% CI = 0.18, 0.03; P < .01) increase in mean willingness to engage in specific behaviors postmessaging, respectively (Table 5).

Action steps

Around 82% (491/602) of respondents stated that they were very/somewhat likely to not pressure their healthcare professional to prescribe antibiotics. However, more participants (516/602; 86%) were very/somewhat likely to ask their doctor for alternative steps to taking antibiotics when they were feeling ill. On the other hand, talking to a friend about the dangers of antibiotic resistance was the least popular action step, with only 67% (403/602) of the participants indicating that they were very/somewhat likely to do so (Table 6).

Discussion

This article explores the effects of communication strategies surrounding antibiotic resistance. Results provide a rudimentary knowledge of patients’ preferences in sources, message content, channels, and their expectations related to antibiotic resistance. Understanding how these communication features resonate with patients may allow providers and practitioners to better communicate topics related to antibiotic resistance.

People not only trusted doctors as a source, but they also preferred to use them as a channel for information on antibiotic resistance. Around 60% (177/299) of participants placed high trust in their doctor to inform them about the danger and implications of antibiotic resistance, and 72% (441/610) indicated them as a preferred channel. This distinction is important, given that doctors both possess the relevant knowledge to convey (ie, information source) and are the conduit through which this information is interpersonally shared with patients (ie, channel). These findings indicate their ability to effectively play both roles.

Email and targeted advertisements were least preferred methods of communication, as most participants preferred to receive this information from a trusted medical source, namely their doctor or another healthcare provider. This suggests that, although widely available, direct messages may not be the most effective way to address patients regarding antibiotic resistance. Not only is it important for a trustworthy source (eg, doctor, field experts, CDC) to provide these messages, but they must also do so in an appropriate channel (eg, interpersonally, through a healthcare website, in a medical magazine).

Messages that focused on the threat of resistance (eg, antibiotics not working when needed; Table 3) were perceived as the most convincing. These findings are largely in line with prior research that has successfully implemented fear appeals to encourage proper antibiotic use. Reference Sirota and Juanchich10 Importantly, these messages must be coupled with empowering content that maintains patients’ feelings of efficacy (ie, that they are capable of completing the proposed action) to be effective. Reference Roope, Tonkin-Crine and Herd9

This focus on threat coincided with perceived benefits of resistance reduction, such that participants found prevention of superbugs and rendering antibiotics effective, specifically for self, to be the most relevant benefits. The emphasis on the self is somewhat at odds with current recommendations to “emphasize that this is a universal issue.” 14 Only 7% (29/416) of participants noted societal health as a benefit in antibiotic resistance reduction. Thus, we recommend perhaps the ”it affects everyone, including you” (our emphasis) is the critical element here. 14

Postmessaging, individuals identified that they were very/somewhat likely to ask their doctor or healthcare professional if there were other steps they could take to feel better without taking antibiotics (516/602; 86%), as well as to promise never to pressure their healthcare provider to prescribe antibiotics (491/602; 82%). However, they were not as likely to talk to close friends and family about the dangers of antibiotic resistance, with 27% of respondents saying they were not likely to do this (Table 6). Given that family/friends are considered relatively undesirably methods of communication (Table 4), these messages appear effective for driving patients to their trusted source and preferred channel.

Table 6. Likelihood of taking particular behavioral action steps (postexposure to messaging only)

Items were measured on a 4-point Likert scale from 1 “very likely” to 4 “not likely at all.”

When measuring message effects, we saw a significant (P < .001) increase in concern about antibiotic resistance as well as an increase in willingness to reduce antibiotic use for both bacterial (Group A; P < .001) and viral (Group B; P < .01) infections. We also saw a decrease in participants’ prescription expectations for some symptoms. Expectation for cough (P < .001), and sore throat (P < .05) were significantly decreased after being exposed to the message.

Limitations

Most notably, this survey was conducted in 2017 before the COVID-19 pandemic. Research has found that the pandemic impacted the U.S. public’s impression of the CDC as well as general knowledge about the effectiveness of antibiotics against viral infections. Reference Pollard and Davis15 Future efforts will need to be taken to replicate these findings in newer samples with additional questions about antibiotic use to understand how the pandemic and drug usage may have influenced the relationships found here.

In addition, this study does not examine SMCR preferences by target audience variables. Reference Chryst, Marlon, Van Der Linden, Leiserowitz, Maibach and Roser-Renouf16 For example, it could be the case that more educated audiences have distinct preferences from those with significantly less education. Moreover, communication research has made clear that targeting by demographics is the least satisfactory form of targeting. Reference Armstrong, Adam, Denize and Kotler17 Rather, message designers (eg, marketing firms) prefer to target by psychographics such as lifestyle or culture. Reference Armstrong, Adam, Denize and Kotler17 This was beyond the scope of this study but should be carefully considered in future research on antibiotic resistance messaging.

Finally, though results showed that individuals were more concerned with antibiotic resistance and more willing to reduce antibiotic use after being presented with persuasive messaging, we presented nine messages to participants at once and thus do not know which standalone messages are necessarily the most effective. A conjoint analysis that manipulates SMCR elements to compare is a welcome future direction.

Conclusion

These results offer healthcare providers as a useful source and channel for antibiotic resistance information sharing. Furthermore, practitioners may find these results useful in designing a communication campaign message with appropriate messages for patients. We believe that even a basic understanding may allow providers and practitioners to better intervene to reduce antibiotic resistance, whether it be used in clinical care, teaching, or designing health communication campaigns.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/ash.2024.429.

Acknowledgements

We gratefully acknowledge the participants in this study.

Author Contributions

Authors on title page are listed by order of contribution.

Financial support

This project was supported by a grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co. The funder had no role in the design and conduct of the study.

Competing interests

None.

Research transparency and reproducibility

Deidentified data available upon request.

Footnotes

1 In this study, our position was that patients should not expect antibiotics until a provider provides a diagnosis. We recognized that some symptoms were more likely to correlate with the need for an antibiotic--and therefore presented all of the expectation data (versus only an aggregate).

References

Antibiotic resistance threats in the United States, 2019. Centers for Disease Control and Prevention website. Published 2020. https://www.cdc.gov/drugresistance/pdf/threatsreport/2019-ar-threats-report-508.pdf. Accessed 2021.Google Scholar
Ventola, CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Therap 2015;40:277283.Google ScholarPubMed
Cockburn, J, Pit, S. Prescribing behaviour in clinical practice: patients’ expectations and doctors’ perceptions of patients’ expectations a questionnaire study. BMJ 1997;315:520523. doi: 10.1136/bmj.315.7107.520 CrossRefGoogle ScholarPubMed
Mangione-Smith, R, McGlynn, EA, Elliott, MN, Krogstad, P, Brook, RH. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics 1999;103:711718. doi: 10.1542/peds.103.4.711 CrossRefGoogle ScholarPubMed
Davey, P, Pagliari, C, & Hayes, A. The patient’s role in the spread and control of bacterial resistance to antibiotics. Clin Microbiol Infect 2002;8:4368.CrossRefGoogle Scholar
Hyun, D., Zetts, R. Antibiotics are overprescribed in urgent care. The Pew Charitable Trusts. Published 2018. https://www.pewtrusts.org/en/research-and-analysis/articles/2018/07/16/antibiotics-are-overprescribed-in-urgent-care. Accessed 2024.Google Scholar
Van Hecke, O, Butler, CC, Wang, K, Tonkin-Crine, S. Parents’ perceptions of antibiotic use and antibiotic resistance (PAUSE): a qualitative interview study. J Antimicrobial Chemother 2019;74:17411747. doi: 10.1093/jac/dkz091 CrossRefGoogle Scholar
Thorpe, A, Sirota, M, Orbell, S, Juanchich, M. Effect of information on reducing inappropriate expectations and requests for antibiotics. British J of Psychol 2021;112:804827. doi: 10.1111/bjop.12494 CrossRefGoogle ScholarPubMed
Roope, LSJ, Tonkin-Crine, S, Herd, N, et al. Reducing expectations for antibiotics in primary care: a randomised experiment to test the response to fear-based messages about antimicrobial resistance. BMC Med 2020;18:110. doi: 10.1186/s12916-020-01553-6 CrossRefGoogle ScholarPubMed
Sirota, M, Juanchich, M. Seeing an apocalyptic post-antibiotic future lowers antibiotics expectations and requests. Commun Med 2024;4:141. doi: 10.1038/s43856-024-00567-y CrossRefGoogle Scholar
Berlo, DK. The Process of Communication: An Introduction of Theory and Practice. United States: Holt, Rinehart and Winston; 1960.Google Scholar
Palms, DL, Hicks, LA, Bartoces, M, et al. Comparison of antibiotic prescribing in retail clinics, urgent care centers, emergency departments, and traditional ambulatory care settings in the United States. JAMA Intern Med 2018;178:1267. doi: 10.1001/jamainternmed.2018.1632 CrossRefGoogle ScholarPubMed
Poushter, J, Gubbala, S, Lippert, J. Ipsos KnowledgePanel and Omnibus methodology. Pew Research Center website. Published 2023. https://www.pewresearch.org/global/2023/11/27/methodology-koerber-2023/. Accessed 2024.Google Scholar
Pollard, M, Davis, L. Decline in Trust in the Centers for Disease Control and Prevention During the COVID-19 Pandemic. Rand Health Quart 2022;9:23. doi: 10.7249/RRA308-12 Google ScholarPubMed
Chryst, B, Marlon, J, Van Der Linden, S, Leiserowitz, A, Maibach, E, & Roser-Renouf, C. Global warming’s “six Americas short survey”: Audience segmentation of climate change views using a four question instrument. Environ Commun 2018; 12: 11091122.CrossRefGoogle Scholar
Armstrong, G, Adam, S, Denize, S, & Kotler, P. Principles of Marketing. Australia; Pearson; 2014.Google Scholar
Figure 0

Table 1. Sample demographics

Figure 1

Figure 1. Flow chart of survey order and experimental design for group A and B.

Figure 2

Table 2. Source trust ratings

Figure 3

Table 3. Messages: ratings of how convincing each message was and ranking of benefits to help reduce antibiotic resistance

Figure 4

Table 4. Preferences for channels and benefits of antibiotic resistance reduction

Figure 5

Table 5. Evidentiary message effects of antibiotic expectation by symptoms, antibiotic resistance concern, and action step willingness

Figure 6

Table 6. Likelihood of taking particular behavioral action steps (postexposure to messaging only)

Supplementary material: File

Wade et al. supplementary material

Wade et al. supplementary material
Download Wade et al. supplementary material(File)
File 76.8 KB